Effects of the CB1 receptor antagonists AM6545 and AM4113 on metabolic syndrome-induced prostatic hyperplasia in rats. (2023). Biomolecules and Biomedicine, 23(6), 1069–1078. https://doi.org/10.17305/bb.2023.9173